Table 1.
Characteristic | Value |
---|---|
Total number of patients | 9 |
Age, years median (range) | 53 (43–68) |
Gender | |
Male | 9 |
Female | 0 |
Race | |
Black | 1 (11 %) |
White | 8 (89 %) |
Other | 0 |
Performance status | |
Median | 1 |
Range | 0–1 |
Primary site | |
Oral | 0 |
Oropharynx | 8 (89 %) |
Hypopharynx | 0 |
Larynx | 1 (11 %) |
Nasopharynx | 0 |
Nasal/paranasal | 0 |
Disease at enrollment | |
Locoregional recurrence only | 2 (22 %) |
Metastatic disease | 7 (78 %) |
Sites of metastatic disease | |
Lung | 5 |
Bone | 2 |
Liver | 1 |
Other | 1 (retroperitoneum) |
Number of prior chemotherapy regimens | |
0 | 2 (22 %) |
1 | 3 (33 %) |
2 | 2 (22 %) |
3+ | 2 (22 %) |